Interleukin-7 for HIV patients with low CD4 counts
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This study tests a medicine called IL-7 (interleukin-7) that may help raise the number of CD4 cells (a type of immune cell) in people with HIV whose CD4 counts stay low despite effective HIV treatment. The goal is to see if it can improve immune function and potentially reduce infection risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 65 years old.
- Have been on HIV treatment (cART) for at least 3 years without changing drugs in the last 3 months.
- Have an undetectable HIV viral load (under 50 copies) for at least 30 months.
- Have a CD4 count between 100 and 350 (measured twice, at least 3 months apart).
- Not have taken IL-7 or IL-2 before, and not have autoimmune diseases like lupus or psoriasis.
- Agree to use barrier contraception (like condoms) during the study and for 3 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a small protein called IL-15 can help your immune system keep HIV under control after pausing your daily HIV medications. You will stop your meds for a short time under careful monitoring, and the hope is that your body might learn to fight HIV without daily pills.
This Phase 1 trial tests two new HIV vaccines (DV700P-RNA and DV701B1.1-RNA) combined with a monitored break from HIV medications in people with well-controlled HIV. The goal is to see if this approach safely strengthens the immune system's ability to fight HIV.
This study is testing three experimental antibodies (ePGT121v1-LS, PGDM1400LS, and VRC07-523LS) that may help prevent HIV. It’s looking at their safety and how long they stay in the body. Healthy volunteers without HIV can join.
This trial tests a new injectable treatment called LP-98 for people with HIV who have never taken HIV medications before. It aims to see if the drug is safe and can help lower the virus in your body.
This study tests an experimental drug called JL18008 in people with HIV who have been on stable HIV medications for years but whose immune systems (CD4 cells) haven't recovered as expected. The drug may help boost immune function in these patients.
This Phase 1/2 study tests a long-acting IL-7 medicine to raise low CD4 immune cells in people with idiopathic CD4 lymphopenia. Because this is a dose-escalation study, the goal is to check safety and see if the treatment affects immune cell levels.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.